PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
University of Pennsylvania
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Pennsylvania (3)
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2017
-
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
Annals of Oncology, Vol. 28, Núm. 10, pp. 2517-2525
2015
-
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773